Evidence map›Paper›PMID 33411174›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Acquisition of multidrug-resistant bacteria and encoding genes among French pilgrims during the 2017 and 2018 Hajj.

Van-Thuan Hoang, Thi-Loi Dao, Tran Duc Anh Ly, Frédérique Gouriet, Linda Hadjadj, Khadidja Belhouchat, Kamel Larbi Chaht, Saber Yezli, Badriah Alotaibi, Didier Raoult and 5 more

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Transmission of Antimicrobial Resistant Bacteria at the Hajj: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  5. Molecular Characterization ofAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Van-Thuan HoangIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Thi-Loi DaoIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Tran Duc Anh LyIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Frédérique GourietInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Linda HadjadjInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Khadidja BelhouchatIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Kamel Larbi ChahtIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Saber YezliThe Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Badriah AlotaibiThe Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Didier RaoultInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Philippe ParolaIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Sophie Alexandra BaronInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Vincent Pommier de SantiIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France.
Jean-Marc RolainInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Philippe GautretIRD, AP-HM, SSA, VITROME, Aix Marseille University, Marseille, France. philippe.gautret@club-internet.fr.ORCID http://orcid.org/0000-0002-1664-958X

Funding

Agence Nationale de la Recherche ANR-10-IAHU-03
6 · The paper itself

Abstract

The objective of this study is to determine the acquisition of multidrug-resistant (MDR) bacteria and antibiotic resistance-encoding genes by French Hajj pilgrims and associated risk factors. Pilgrims traveling during the 2017 and 2018 Hajj were recruited. All pilgrims underwent two successive systematic nasopharyngeal and rectal swabs, pre- and post-Hajj. Specific culture media were used to screen for MDR bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant bacteria, and extended spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E). qPCR was used to identify antibiotic resistance-encoding genes from cultured isolates. Direct screening of genes encoding for colistin resistance (mcr-1, 2, 3, 4, 5, and 8) from nasopharyngeal and rectal swabs was performed using qPCR, and positive qPCR results were simultaneously tested by sequencing. There were 268 pilgrims included. The percentage of pilgrims acquiring MDR bacteria during the Hajj was 19.4%. A total of 81 strains were isolated (1 carbapenem-resistant Acinetobacter baumannii, 12 MRSA, and 68 ESBL-E). ESBL-E strains were found in rectal samples of 6.0% pilgrims pre-Hajj and of 16.4% pilgrims post-Hajj. Only 0.4% pilgrims were positive for CARB post-Hajj and 1.9% carried nasal MRSA pre- and post-Hajj. In addition, 23 (8.6%) post-Hajj rectal swabs were positive for mcr genes (19 mcr-1 gene and 4 mcr-4 gene). No significant association was found between co-factors and acquisition of MDR bacteria or mcr genes. MDR bacteria and genes are acquired by pilgrims during the Hajj mass gathering. Rationalization of antibiotic consumption and implementation of measures to prevent transmission of bacteria among pilgrims during the event are of paramount importance.

Indexed as

Drug Resistance, Multiple, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsBacteriaBacterial ProteinsFemaleHumansMaleMiddle AgedNasopharynxRectumReligionSaudi ArabiaTravelAnti-Bacterial AgentsBacterial ProteinsColistinESBL-EHajjMRSAMultidrug resistant bacteriaPilgrimsRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.